A Randomized, Blinded, Single-center, Parallel Controlled, Phase II Clinical Trial to Evaluate Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged From 3 Months to 5 Years Old
Latest Information Update: 06 May 2021
At a glance
- Drugs Shigella dysenteriae vaccine (Primary) ; Hib vaccine
- Indications Dysentery
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Beijing Zhifei Lvzhu Biopharmaceutical
- 06 May 2021 New trial record